June 1, 2022 02:26 PM EDTUpdated 04:40 PM
Pharma

Ab­b­Vie in po­si­tion to be­come largest phar­ma by 2028, nar­row­ly edg­ing out Roche — re­port

Paul Schloesser

Associate Editor

Thanks to the suc­cess of its Covid-19 vac­cine Comir­naty, Pfiz­er cur­rent­ly holds the top spot in Eval­u­ate Phar­ma’s rank­ing of phar­ma com­pa­nies by sales …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

A service from the Financial Times